- Condition: Severe Spasticity
Intervention: Drug: Gablofen® 3 mg/mL (baclofen injection)
Sponsors: CNS Therapeutics; CNS Therapeutics; Pacific-Link Regulatory Consulting LLC
Not yet recruiting - verified March 2012 - Condition: Cannabis-use Disorders
Intervention: Drug: Tiagabine
Sponsors: University of Kentucky; University of Kentucky
Recruiting - verified January 2012 - Conditions: Ultrasound; CT Scans; MRIs
Interventions: Drug: Dexmedetomidine; Drug: Midazolam; Drug: Fentanyl
Sponsors: Hospira, Inc.; Hospira, Inc.
Recruiting - verified April 2012 - Condition: Insomnia
Interventions: Drug: Dexmedetomidine; Drug: Zolpidem; Drug: Oral Placebo; Drug: Normal Saline placebo.
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified December 2011 - Condition: Anesthesia
Interventions: Drug: Midazolam; Drug: Fentanyl; Drug: Morphine
Sponsors: Hospira, Inc.; Hospira, Inc.
Recruiting - verified April 2012 - Condition: Suicidal Ideation
Interventions: Drug: Ketamine; Drug: Midazolam
Sponsors: Mount Sinai School of Medicine; James Murrough
Recruiting - verified January 2012 - Condition: Insomnia
Interventions: Drug: E2006 1.0 mg; Drug: E2006 2.5 mg; Drug: E2006 5.0 mg; Drug: E2006 10.0 mg; Drug: E2006 25.0 mg; Drug: E2006 50.0 mg; Drug: E2006 100 mg; Drug: E2006 200 mg; Drug: zolpidem 10 mg; Drug: zolpidem - matched placebo; Drug: E2006 - matched placebo
Sponsors: Eisai Inc.; Eisai Inc.
Recruiting - verified April 2012 - Condition: Spasticity
Interventions: Drug: Baclofen ER Capsules; Drug: Placebo GRS
Sponsors: Sun Pharma Advanced Research Company Limited; Sun Pharma Advanced Research Company Limited
Not yet recruiting - verified October 2011 - Conditions: Cerebral Palsy; GERD
Interventions: Drug: Baclofen; Drug: placebo
Sponsors: Children's Hospital Boston; Children's Hospital Boston; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified June 2011 - Condition: Multiple Sclerosis
Intervention: Drug: arbaclofen placarbil
Sponsors: XenoPort, Inc.; XenoPort, Inc.
Recruiting - verified September 2011 - Condition: Multiple Sclerosis
Interventions: Drug: arbaclofen placarbil; Drug: Placebo; Drug: arbaclofen placarbil; Drug: arbaclofen placarbil
Sponsors: XenoPort, Inc.; XenoPort, Inc.
Recruiting - verified September 2011 - Condition: Fragile X Syndrome
Interventions: Drug: arbaclofen; Drug: arbaclofen; Drug: arbaclofen; Drug: Placebo
Sponsors: Seaside Therapeutics, Inc.; Seaside Therapeutics, Inc.
Recruiting - verified March 2012 - Condition: GERD
Interventions: Device: Nissen fundoplication; Drug: baclofen; Drug: Desipramine
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified January 2012 - Condition: Healthy Volunteers
Interventions: Drug: Almorexant; Drug: Almorexant; Drug: Zolpidem 10mg; Drug: Placebo
Sponsors: Northern California Institute of Research and Education; Northern California Institute of Research and Education; U.S. Army Medical Research and Materiel Command
Recruiting - verified August 2010 - Condition: Nicotine
Intervention:
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute on Drug Abuse (NIDA)
Recruiting - verified December 2011 - Condition: Neonatal Abstinence Syndrome
Interventions: Drug: Clonidine; Drug: Phenobarbital
Sponsors: Baystate Medical Center; Baystate Medical Center
Recruiting - verified April 2012 - Condition: Severe Spasticity
Intervention: Drug: intrathecal baclofen
Sponsors: Medtronic International Trading Sarl; Medtronic International Trading Sarl
Recruiting - verified May 2012 - Conditions: Hepatitis C; Alcohol Use Disorders
Interventions: Drug: baclofen; Drug: placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified January 2012 - Conditions: Dementia; Alzheimer Disease; Dementia, Vascular; Sleep Disorders; Circadian Dysregulation
Interventions: Drug: Zolpidem CR; Drug: Zolpidem CR placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Conditions: Sleep; Burns
Interventions: Drug: zolipidem; Drug: ramelteon
Sponsors: Shriners Hospitals for Children; Shriners Hospitals for Children; Children's Hospital Medical Center, Cincinnati
Recruiting - verified May 2012 - Condition: Schizophrenia
Interventions: Drug: Tiagabine; Drug: Placebo
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; Dartmouth-Hitchcock Medical Center
Recruiting - verified July 2011 - Condition: Epilepsy
Intervention: Drug: Muscimol
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified March 2012
 |
GABA Agonists Clinical Trials |
